CompletedNot Applicable

Molecular Characterization of Penile Cancers in Developing Countries

Brazil24 participantsStarted 2021-12-17

Plain-language summary

This study explores penile squamous cell carcinoma (PSCC) in Brazil, a rare cancer associated with factors like poor hygiene and HPV infection, using next-generation sequencing to investigate its genomic profiles in 24 deceased patients with advanced PSCC.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Men ≥ 18 years of age; * Diagnosis of locally advanced or metastatic squamous-cell penile carcinoma; * Have received at least one treatment for advanced disease (surgery, radiotherapy and/or chemotherapy); * Available representative tumor block of formalin-fixed and paraffin-embedded (FFPE) archive, from primary or metastasis; * Patients must be already deceased at time of data collection. Exclusion Criteria: * Patients without medical record available (lost, empty or irretrievable clinical information).

What they're measuring

Biomarker Profiling of Penile Carcinoma by NGS

Timeframe: Through study completion, an average of 2 years

Trial details

NCT IDNCT06068998

SponsorLatin American Cooperative Oncology Group

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-08-03

View on ClinicalTrials.gov More Penile Squamous Cell Carcinoma trials